Fingerprint
Dive into the research topics of 'In Vivo Bioengineering of Beta Cells with Immune Checkpoint Ligand as a Treatment for Early-Onset Type 1 Diabetes Mellitus'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
In Vivo Bioengineering of Beta Cells with Immune Checkpoint Ligand as a Treatment for Early-Onset Type 1 Diabetes Mellitus
Kin Man Au, Roland Tisch, Andrew Z. Wang
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations